New ETF Book by Larry Connors - Click here to read more
-- Q4'09 Revenue guidance of $255 million to $270 million
Teradyne, Inc. (NYSE: TER | Quote | Chart | News | PowerRating) reported revenue of $262 million for the third quarter of 2009. Semiconductor Test revenue totaled $173 million and Systems Test Group revenue totaled $89 million. On a non-GAAP basis, Teradyne's income from continuing operations in the third quarter was $24.8 million, or $0.14 per diluted share, which excluded restructuring charges, acquired intangible asset amortization and special items. GAAP income from continuing operations for the third quarter was $6.7 million, or $0.04 per diluted share.
Bookings in the third quarter of 2009 were $288 million of which $233 million was in Semiconductor Test and $55 million in Systems Test Group.
Guidance for the fourth quarter of 2009 is for revenue of $255 million to $270 million, with Non-GAAP net income per share of $0.12 to $0.17 and GAAP net income per share between $0.04 and $0.09. Non-GAAP guidance excludes restructuring charges, acquired intangible asset amortization and special items.
"Our Semiconductor and Systems Test businesses continued to gain strength through the quarter driving our return to operating profitability and positive outlook for Q4," said Teradyne President and CEO Mike Bradley. "We reached a major milestone in our expansion into new markets as we received initial orders for the UltraFLEX-M high-speed memory test system."
Webcast
A webcast to discuss third quarter 2009 results, along with management's business outlook will be held at 10 a.m. EDT, Thursday, October 29. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. The webcast replay will be available on www.teradyne.com. In addition, a conference call replay will be available approximately two hours after the call. The replay number in the U.S. & Canada is 800-642-1687. The replay number outside the U.S. & Canada is 706-645-9291. The pass code for both numbers is 36016837. The replay will be available via phone and web site through November 13, 2009.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Teradyne reports non-GAAP results in order to better assess and reflect operating performance. Management believes the non-GAAP measures help indicate Teradyne's baseline performance before gains, losses or other charges that may not be indicative of our current core business or future outlook. Teradyne believes these non-GAAP measures will aid investors' overall understanding of its results by providing a higher degree of transparency for certain expenses and providing a level of disclosure that will help investors understand how Teradyne plans and measures its own business. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on "Investors" and then selecting the "GAAP to Non-GAAP Reconciliation" link. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.
About Teradyne
Teradyne (NYSE:TER) is a leading supplier of Automatic Test Equipment used to test complex electronics used in the consumer electronics, automotive, computing, telecommunications, and aerospace and defense industries. In 2008, Teradyne had sales of $1.1 billion. For more information, visit www.teradyne.com. Teradyne(R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries. All product names are trademarks of Teradyne, Inc. (including its subsidiaries) or their respective owners.
Safe Harbor Statement
The forward-looking statements included in this release are made only as of the date of publication. Teradyne disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
This release contains forward-looking statements regarding future business prospects, Teradyne's results of operations and market conditions. Such statements are based on the current assumptions and expectations of Teradyne's management and are neither promises nor guarantees of future performance. You can identify these forward-looking statements based on the context of the statements and by the fact that they use words such as "will," "anticipate," "expect," "project," "intend," "plan," "believe," "target" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. There can be no assurance that management's estimates of Teradyne's future results or other forward looking statements will be achieved. Important factors that could cause actual results to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased product demand; delays in new product introductions; lack of customer acceptance of new products; unanticipated delays in or costs and expenses relating to the implementation of cost reduction plans; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the "Risk Factors" section of Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and Quarterly Report on Form 10-Q for the period ended July 5, 2009. The forward-looking statements provided by Teradyne in this press release represent management's views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management's views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne's views as of any date subsequent to the date of this release.
TERADYNE, INC. REPORT FOR THIRD FISCAL QUARTER OF 2009
CONDENSED CONSOLIDATED OPERATING STATEMENTS
(In thousands, except per share amounts)
Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Net Revenues $ 262,162 $ 169,580 $ 297,255 $ 552,350 $ 912,275
Cost of Revenues (1) 155,407 122,451 169,325 365,106 491,994
Gross Profit 106,755 47,129 127,930 187,244 420,281
Operating Expenses:
Engineering and Development 38,266 38,451 52,969 123,915 164,272
Selling and Administrative 46,314 47,257 58,614 148,944 189,298
Acquired Intangible Asset Amortization 8,214 8,214 5,034 24,667 13,671
In-process Research and Development - - - - 1,100
Restructuring and Other, net (2) 5,189 15,270 28,589 36,424 53,100
Operating Expenses 97,983 109,192 145,206 333,950 421,441
Income/(Loss) from Operations 8,772 (62,063 ) (17,276 ) (146,706 ) (1,160 )
Interest & Other (3) (3,597 ) (6,905 ) (3,111 ) (15,555 ) 4,419
Income/(Loss) from Continuing Operations Before Income Taxes 5,175 (68,968 ) (20,387 ) (162,261 ) 3,259
Income Tax (Benefit)/Provision (1,500 ) (2,200 ) 3,070 (11,500 ) 13,270
Income/(Loss) from Continuing Operations 6,675 (66,768 ) (23,457 ) (150,761 ) (10,011 )
Income from Discontinued Operations Before Income Taxes - - 768 - 768
Income Tax (Benefit)/Provision - - - - -
Income from Discontinued Operations - - 768 - 768
Net Income/(Loss) $ 6,675 $ (66,768 ) $ (22,689 ) $ (150,761 ) $ (9,243 )
Income/(Loss) per Common Share from
Continuing Operations:
Basic $ 0.04 $ (0.39 ) $ (0.14 ) $ (0.87 ) $ (0.06 )
Diluted $ 0.04 $ (0.39 ) $ (0.14 ) $ (0.87 ) $ (0.06 )
Net Income/(Loss) per Common Share:
Basic $ 0.04 $ (0.39 ) $ (0.13 ) $ (0.87 ) $ (0.05 )
Diluted $ 0.04 $ (0.39 ) $ (0.13 ) $ (0.87 ) $ (0.05 )
Weighted Average Common Shares - Basic 174,495 173,022 168,769 173,216 171,058
Weighted Average Common Shares - Diluted 180,792 173,022 168,769 173,216 171,058
Net Orders $ 288,048 $ 227,331 $ 198,072 $ 651,725 $ 827,067
(1) Cost of Revenues includes: Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Provision for Excess and Obsolete Inventory $ 6,915 $ 11,491 $ 21,715 $ 27,003 $ 24,969
Cost for Purchase Accounting Inventory Step-up 5,700 3,924 - 10,863 4,346
Sale of Previously Written Down Inventory (588 ) - (528 ) (588 ) (1,442 )
Insurance Recovery Gain - (1,000 ) - (1,000 ) -
$ 12,027 $ 14,415 $ 21,187 $ 36,278 $ 27,873
(2) Restructuring and other, net consists of: Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Facility Related $ 4,419 $ - $ 3,404 $ 4,419 $ 16,424
Employee Severance 1,237 14,976 2,620 32,891 15,243
Eagle Test Purchase Accounting Adjustment & Other (467 ) (774 ) - (1,954 ) -
Long-Lived Asset Impairment - 1,068 - 1,068 550
Loss on Sale of Real Estate - - 22,565 - 20,883
$ 5,189 $ 15,270 $ 28,589 $ 36,424 $ 53,100
(3) Interest and Other includes: Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Amortization of GAAP Imputed Convertible Debt Discount $ 2,329 $ 2,251 $ - $ 4,580 $ -
Expense for Deferred Debt Financing Costs as a Result of
Repayment and Termination of the Revolving Line of Credit - 2,488 - 2,488 -
Other-Than-Temporary Impairment and Realized
(Gains)/Losses on Marketable Securities (572 ) - 8,437 2,000 8,437
Gain on Sale of an Equity Investment - - (2,811 ) - (2,811 )
Gain on Life Insurance - - (1,352 ) - (1,352 )
Charge for Acquisition Financing Fees - - 1,227 - 1,227
$ 1,757 $ 4,739 $ 5,501 $ 9,068 $ 5,501
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
October 4, 2009 December 31, 2008
Assets
Cash and Cash Equivalents $ 406,741 $ 322,705
Marketable Securities 5,735 -
Accounts Receivable 139,693 109,625
Inventories (1) 111,970 168,451
Deferred Tax Assets 17,561 16,988
Prepayments and Other Current Assets 60,348 60,884
742,048 678,653
Net Property, Plant and Equipment 250,151 298,449
Long-Term Marketable Securities 55,033 51,613
Intangible Assets 160,592 186,998
Other Assets 18,669 19,534
$ 1,226,493 $ 1,235,247
Liabilities
Accounts Payable 70,613 61,164
Current Debt (2) 2,237 122,500
Accrued Employees' Compensation and Withholdings 52,053 73,521
Deferred Revenue and Customer Advances 127,993 58,030
Other Accrued Liabilities 50,184 51,748
303,080 366,963
Retirement Plans Liabilities 134,465 125,877
Deferred Tax Liabilities 3,045 8,730
Other Long-Term Liabilities 23,623 27,565
Long-Term Debt (2) (3) 138,970 -
603,183 529,135
Shareholders' Equity 623,310 706,112
$ 1,226,493 $ 1,235,247
(1) As of October 4, 2009 and December 31, 2008, Inventories
included approximately $4.5 million and $15.4 million, respectively,
for Eagle Test inventory fair value step-up.
(2) On March 31, 2009, we entered into a loan agreement in Japan
for approximately $10 million. The loan has a term of 5 years and
a fixed interest rate of 1.4%. At October 4, 2009, $2.2 million of
the outstanding loan principal is included in current debt and
$7.8 million is classified as long-term debt.
(3) On March 31, 2009, in connection with our convertible note
offering, we entered into convertible note hedge and warrant
transactions. These transactions are expected to reduce the
potential dilution to Teradyne's common stock upon maturity of the
convertible notes. On April 6, 2009, the convertible note and
convertible note hedge and warrant transactions closed and we netted
approximately $163 million of cash, before paying off the $122.5
million bank revolver.
For information on possible dilution related to the convertible
note, investors should access Teradyne's website at www.teradyne.com
and click on "Investors" and then select the "Financial Data" link.
GAAP to Non-GAAP Earnings Reconciliation
References by the Company to non-GAAP income/(loss) and non-GAAP
income/(loss) per share refer to income/(loss) from continuing
operations or income/(loss) per common share from continuing
operations excluding goodwill impairment, in-process research and
development, amortization of the GAAP imputed convertible debt
discount, write-off of credit line debt issue costs, restructuring
and other, net, certain inventory provision reversals, fair value
inventory step-up related to Nextest and Eagle Test,
(losses)/gains on marketable securities and acquired intangible
asset amortization, as well as applicable adjustments to profit
sharing and income taxes due to these exclusions. GAAP requires
that these items be included in determining income/(loss) from
continuing operations. Non-GAAP income/(loss) from continuing
operations (which is the basis for non-GAAP income/(loss) from
continuing operations per share) gives an indication of Teradyne's
baseline performance before gains, losses or other charges that
may notbe indicative of our current core business or future
outlook.
The Company believes these non-GAAP measures will aid investors'
overall understanding of the Company's results by providing a higher
degree of transparency for certain expenses and providing a level of
disclosure that will help investors understand how the Company plans
and measures its own business. However, the presentation of non-GAAP
measures is not meant to be considered in isolation or as a
substitute for, or superior to, financial information provided in
accordance with GAAP.
(In millions, except per share amounts)
Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Net Revenues $ 262.2 $ 169.6 $ 297.3 $ 552.4 $ 912.3
Gross Margin - GAAP $ 106.8 40.7 % $ 47.1 27.8 % $ 127.9 43.0 % $ 187.2 33.9 % $ 420.3 46.1 %
Inventory step-up reversal (1) 5.7 3.9 - 10.9 4.3
Insurance recovery - (1.0 ) - (1.0 ) -
Inventory provision reversal (2) (0.6 ) - (0.5 ) (0.6 ) (1.4 )
Profit sharing adjustment (3) (0.4 ) - - (0.4 ) (0.3 )
Gross Margin - non-GAAP $ 111.5 42.5 % $ 50.0 29.5 % $ 127.4 42.9 % $ 196.1 35.5 % $ 422.9 46.4 %
Income/(Loss) from Operations - GAAP $ 8.8 3.4 % $ (62.1 ) -36.6 % $ (17.3 ) -5.8 % $ (146.7 ) -26.6 % $ (1.2 ) -0.1 %
Acquired intangible asset amortization 8.2 8.2 5.0 24.7 13.7
Inventory step-up reversal (1) 5.7 3.9 - 10.9 4.3
Restructuring and other, net (4) 5.2 15.3 28.6 36.4 53.1
Inventory provision reversal (2) (0.6 ) - (0.5 ) (0.6 ) (1.4 )
In-process research and development - - - - 1.1
Insurance recovery - (1.0 ) - (1.0 ) -
Profit sharing adjustment (3) (2.2 ) - - (2.2 ) (1.5 )
Income/(Loss) from Operations - non-GAAP $ 25.1 9.6 % $ (35.7 ) -21.0 % $ 15.8 5.3 % $ (78.5 ) -14.2 % $ 68.1 7.5 %
Income/(Loss) from Continuing Operations - GAAP $ 6.7 2.6 % $ (66.8 ) -39.4 % $ (23.5 ) -7.9 % $ (150.8 ) -27.3 % $ (10.0 ) -1.1 %
Acquired intangible asset amortization 8.2 8.2 5.0 24.7 13.7
Inventory step-up reversal (1) 5.7 3.9 - 10.9 4.3
Restructuring and other, net (4) 5.2 15.3 28.6 36.4 53.1
Interest and other (5) 1.8 4.7 5.5 9.1 5.5
Inventory provision reversal (2) (0.6 ) - (0.5 ) (0.6 ) (1.4 )
In-process research and development - - - - 1.1
Insurance recovery - (1.0 ) - (1.0 ) -
Profit sharing adjustment (3) (2.2 ) - - (2.2 ) (1.5 )
Income tax adjustment (6) - - - (2.9 ) 0.2
Income/(Loss) from Continuing Operations - non-GAAP $ 24.8 9.5 % $ (35.7 ) -21.0 % $ 15.1 5.1 % $ (76.4 ) -13.8 % $ 65.0 7.1 %
GAAP Income/(Loss) per Common Share from Continuing Operations - $ 0.04 $ (0.39 ) $ (0.14 ) $ (0.87 ) $ (0.06 )
Basic
Non-GAAP Income/(Loss) per Common Share from Continuing Operations - $ 0.14 $ (0.21 ) $ 0.09 $ (0.44 ) $ 0.38
Basic
GAAP and Non-GAAP Weighted Average Common Shares - Basic 174.5 173.0 168.8 173.2 171.1
GAAP Income/(Loss) per Common Share from Continuing Operations - $ 0.04 $ (0.39 ) $ (0.14 ) $ (0.87 ) $ (0.06 )
Diluted
Non-GAAP Income/(Loss) per Common Share from Continuing Operations - $ 0.14 $ (0.21 ) $ 0.09 $ (0.44 ) $ 0.37
Diluted
GAAP Weighted Average Common Shares - Diluted 180.8 173.0 168.8 173.2 171.1
Non-GAAP Weighted Average Common Shares - Diluted 179.0 173.0 170.3 173.2 173.4
(1) Reversal of Nextest and Eagle Test purchase accounting inventory
step-up.
(2) Reversal of previously written down inventory for non-FLEX
products in the Semiconductor Test Division.
(3) Profit sharing adjustment for non-GAAP items.
(4) Restructuring and other, net consists of (in millions):
Quarter Ended: Nine Months Ended:
October 4, 2009 July 5, 2009 September 28, 2008 October 4, 2009 September 28, 2008
Facility Related $ 4.4 $ - $ 3.4 $ 4.4 $ 16.4
Employee Severance 1.2 15.0 2.6 32.9 15.2
Eagle Test Purchase Accounting Adjustment & Other (0.4 ) (0.8 ) - (2.0 ) -
Long-Lived Asset Impairment - 1.1 - 1.1 0.6
Loss on Sale of Real Estate - - 22.6 - 20.9
$ 5.2 $ 15.3 $ 28.6 $ 36.4 $ 53.1
(5) For the quarter and nine months ended October 4, 2009,
Interest and Other included amortization of the GAAP imputed
convertible debt discount. For the quarter ended July 5, 2009 and
nine months ended October 4, 2009, Interest and Other included a
charge to expense deferred debt financing costs as a result of the
repayment and termination of Teradyne's revolving line of credit.
For the nine months ended October 4, 2009, Interest and Other
included a charge for other-than-temporary impairment and realized
(losses)/gains on marketable securities.
(6) Income tax adjustment for non-GAAP items. For the nine months
ended October 4, 2009, the income tax adjustment related to a
discrete foreign exchange item.
For press releases and other information of interest to investors,
please visit Teradyne's homepage on the World Wide Web at http://www.teradyne.com.
SOURCE: Teradyne, Inc.
Teradyne, Inc. Andy Blanchard, 978-370-2425 Investor Relations investorrelations@teradyne.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.